文献速递糖尿病

大型痴呆队列中的糖尿病:瑞典痴呆登记处的临床特征与治疗

Diabetes in a Large Dementia Cohort: Clinical Characteristics and Treatment From the Swedish Dementia Registry.
PubMed 文献 · Diabetes Care · 2017-06-27

基于瑞典痴呆登记处的横断面登记研究纳入29630例痴呆患者,其中4881例(16.5%)诊断为糖尿病。糖尿病与痴呆诊断时年龄较低、男性、血管性痴呆和混合性痴呆相关,而路易体痴呆、帕金森病痴呆和使用抗抑郁药在糖尿病患者中较少见。阿尔茨海默病合并糖尿病患者接受胆碱酯酶抑制剂和美金刚治疗显著较少。

要点

  • 痴呆患者中糖尿病患病率为16.5%(4881/29630)。
  • 糖尿病与痴呆诊断时年龄较低(OR 0.97)、男性(OR 1.41)、血管性痴呆(OR 1.17)和混合性痴呆(OR 1.21)相关。
  • 阿尔茨海默病合并糖尿病患者接受胆碱酯酶抑制剂(OR 0.78)和美金刚(OR 0.68)治疗显著较少。

核心结论

  • 糖尿病患者痴呆诊断时年龄更轻,且阿尔茨海默病合并糖尿病患者接受的痴呆药物治疗较少,提示痴呆治疗可能不够理想。
  • 未来研究应评估糖尿病患者在不同痴呆疾病中的生存率和代谢特征差异。

研究设计与样本

  • 基于瑞典痴呆登记处(SveDem)的横断面登记研究,共纳入29630例痴呆患者,其中4881例(16.5%)诊断为糖尿病。

主要发现

  • 完全调整模型中,糖尿病与痴呆诊断时年龄较低(OR 0.97 [99% CI 0.97-0.98])、男性(OR 1.41 [99% CI 1.27-1.55])、血管性痴呆(OR 1.17 [99% CI 1.01-1.36])和混合性痴呆(OR 1.21 [99% CI 1.06-1.39])相关。
  • 路易体痴呆(OR 0.64 [99% CI 0.44-0.94])、帕金森病痴呆(OR 0.46 [99% CI 0.28-0.75])和使用抗抑郁药(OR 0.85 [99% CI 0.77-0.95])在糖尿病患者中较少见。
  • 阿尔茨海默病合并糖尿病患者接受胆碱酯酶抑制剂治疗显著较少(OR 0.78 [99% CI 0.63-0.95]),接受美金刚治疗也显著较少(OR 0.68 [99% CI 0.54-0.85])。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We aimed to investigate the differences in clinical characteristics and pharmacological treatment associated with the presence of diabetes in a large cohort of patients with dementia. RESEARCH DESIGN AND METHODS: A cross-sectional registry-based study was conducted using data from the Swedish Dementia Registry (SveDem). Data on dementia diagnosis, dementia type, and demographic determinants were extracted from SveDem. Data from the Swedish Patient Register and Prescribed Drug Register were combined for the diagnosis of diabetes. Data on antidiabetic, dementia, cardiovascular, and psychotropic medications were extracted from the Swedish Prescribed Drug Register. Logistic regression was used to determine whether the variables were associated with diabetes after adjustment for confounders. In total, 29,630 patients were included in the study, and 4,881 (16.5%) of them received a diagnosis of diabetes. RESULTS: In the fully adjusted model, diabetes was associated with lower age at dementia diagnosis (odds ratio [OR] 0.97 [99% CI 0.97-0.98]), male sex (1.41 [1.27-1.55]), vascular dementia (1.17 [1.01-1.36]), and mixed dementia (1.21 [1.06-1.39]). Dementia with Lewy bodies (0.64 [0.44-0.94]), Parkinson disease dementia (0.46 [0.28-0.75]), and treatment with antidepressants (0.85 [0.77-0.95]) were less common among patients with diabetes. Patients with diabetes who had Alzheimer disease obtained significantly less treatment with cholinesterase inhibitors (0.78 [0.63-0.95]) and memantine (0.68 [0.54-0.85]). CONCLUSIONS: Patients with diabetes were younger at dementia diagnosis and obtained less dementia medication for Alzheimer disease, suggesting less optimal dementia treatment. Future research should evaluate survival and differences in metabolic profile in patients with diabetes and different dementia disorders.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Secnik J, Cermakova P, Fereshtehnejad SM, et al. Diabetes in a Large Dementia Cohort: Clinical Characteristics and Treatment From the Swedish Dementia Registry. Diabetes Care. 2017. PMID: 28655740. doi:10.2337/dc16-2516

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。